Vecura
料金
お問い合わせ
Vecura

プロダクト

  • 料金

会社情報

  • お問い合わせ

リソース

  • ブログ
  • コミュニティ

法務

  • プライバシーポリシー
  • 利用規約
  • トラストセンター

© 2026 NYB AI. All rights reserved.

すべてのシステムが正常に稼働中
Vecura
料金
お問い合わせ
ブログに戻る

Enhance Virtual Screening with Uni-GBSA, Now Available on Vecura

This update enables drug discovery researchers and computational chemists to perform physics-based binding free energy calculations through a guided workflow inside Vecura, eliminating the need to set up complex GROMACS-based technical infrastructure.

May 12, 2026Uni-GBSA
Uni-GBSA
Uni-GBSA is now available on Vecura
vecura.com

What is Uni-GBSA?

Uni-GBSA is an automated, end-to-end workflow designed to perform MM/GB(PB)SA binding free energy calculations for protein-ligand and protein-protein complexes. It streamlines the complex GROMACS pipeline by integrating forcefield parameterization, energy minimization, and molecular dynamics simulation into a unified, high-throughput process. It is especially useful for drug discovery researchers who need to prioritize lead compounds from virtual screening datasets using physics-based scoring.

What can users do with Uni-GBSA on Vecura?

With Uni-GBSA on Vecura, users can:

  • Perform rapid binding free energy calculations for large libraries of docked ligands.
  • Switch seamlessly between energy minimization and full MD-based trajectory analysis.
  • Utilize automated parameter scanning to calibrate GBSA/PBSA settings against experimental data for specific targets.
  • Identify critical binding contacts through automated per-residue energy decomposition analysis.

What the output means

The output provides a structured CSV table containing a comprehensive breakdown of binding free energy components, including van der Waals, electrostatic, polar, and non-polar solvation energies, alongside the calculated total binding free energy ($\Delta$G). Additionally, the system generates performance metrics like Pearson correlation and RMSE when experimental data is provided.

This output should be used to support scientific decision making, helping researchers rank and filter potential therapeutic candidates. It does not replace experimental validation.

Why this matters

In drug discovery, the ability to accurately estimate binding affinity is crucial for transitioning from high-throughput virtual screening to hit-to-lead optimization. Physics-based methods like MM/GBSA provide a deeper understanding of molecular interactions than simple docking scores, but they are often difficult and time-consuming to implement.

Uni-GBSA solves this bottleneck by automating the entire modeling pipeline, reducing the technical barrier to entry. By allowing researchers to calibrate their models using known experimental affinities, it enhances the reliability of in silico predictions, ultimately accelerating the discovery of potent therapeutic leads.

  • Developed by: DP Technology
  • Source: Official GitHub Repository
  • Reference: Briefings in Bioinformatics (2023)

Vecura で Uni-GBSA を試す。

モデルワークスペースを開き、ご自身の入力で評価を始めましょう。

モデルを試す

トピック

binding-free-energyMM/GBSAMM/PBSAmolecular-dynamicsvirtual-screeningdrug-discoveryprotein-ligandprotein-protein

On this page

What is Uni-GBSA?What can users do with Uni-GBSA on Vecura?What the output meansWhy this matters
Vecura

プロダクト

  • 料金

会社情報

  • お問い合わせ

リソース

  • ブログ
  • コミュニティ

法務

  • プライバシーポリシー
  • 利用規約
  • トラストセンター

© 2026 NYB AI. All rights reserved.

すべてのシステムが正常に稼働中